. 2018 Jan 1;9(2):250–255. doi: 10.7150/jca.22318
© Ivyspring International Publisher
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Figure 1.
Progression-free survival for lenvatinib therapy